"Dr Reddy's oncology business in India aims at bringing in a SEA (science, education and accessibility) change in the treatment of cancer in India. Our aim is to facilitate and ensue that our treating physicians get the best information on the latest developments in the treatment of cancer which could led to early detection," the company said in a statement.
Dr Reddy's has partnered with leading specialists from various front line institutes including Tata Memorial Hospitals and All India Institute of Medical Sciences (AIIMS) to set up a lung cancer editorial board for Shvass-the lung cancer repository and the Indian breast cancer resource. The two teams of medical experts will also share their views and observations in the online portals.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)